# AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects

> **NCT02163161** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04965842
- **DRUG:** PF-04965842
- **DRUG:** PF- 04965842

## Key facts

- **NCT ID:** NCT02163161
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163161, "AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02163161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*